Q&A Part 1: Reviewing the Significance of Lebrikizumab for Patients With Skin of Color, With Anabela Cardoso, MD
Daily Derm Times: June 19, 2025
Upadacitinib Induces Long-Term Remission in Refractory Bullous Pemphigoid: A Case Report
VALIANT Survey Shows High Rates of Depression in Patients with Vitiligo